All-at-Once Spatial Proteome Profiling: Insights from PSPro

Study Background and Research Question

Tissues in multicellular organisms display remarkable complexity, composed of myriad cell types with distinct molecular functions and spatial arrangements. Understanding how these cellular populations interact within their microenvironments is pivotal for deciphering both physiological and pathological tissue states. Traditional spatial proteomics platforms—including laser microdissection followed by mass spectrometry (LMD-MS) and multiplexed antibody-based imaging—offer valuable insight but are often constrained by trade-offs among spatial resolution, throughput, and the depth of proteome coverage. These limitations particularly hamper the analysis of rare cell types or subtle spatial heterogeneity within a single tissue slice. The central research question addressed by Mao et al. (2025, Cell Systems) is: How can we achieve comprehensive, cell-type-resolved proteome profiling across complex tissues, while preserving spatial context and maximizing both selectivity and proteome depth?

Key Innovation from the Reference Study

The study presents PSPro (Proximity labeling for Spatial Proteomics), a novel workflow that integrates antibody-directed proximity biotinylation with efficient affinity purification. The PSPro method enables simultaneous capture of proteomes from multiple cell types within a single tissue slice, achieving sub-micrometer spatial resolution. Unlike conventional LMD-MS, which requires serial microdissection of regions or cells and can be throughput-limited, PSPro’s all-at-once strategy is designed to overcome bottlenecks in both precision and coverage. By fine-tuning labeling parameters, PSPro demonstrates high selectivity for target cell types and recovers thousands of proteins—including cell-type-specific markers—enabling in-depth spatial proteome mapping.

Methods and Experimental Design Insights

Mao et al. refined proximity labeling for tissue proteomics by leveraging antibody targeting to direct biotinylation to specific cell populations. Their workflow comprises antibody incubation on fixed tissue slices, enzymatic proximity labeling (using HRP-conjugates and biotin-phenol), and subsequent affinity purification of labeled proteins. Proteomic analysis is performed via mass spectrometry, with spatial resolution preserved by localizing the initial antibody-labeling step.

To benchmark PSPro, the authors compared its performance against established workflows, including flow cytometry-based and LMD-based proteomic methods. They further applied PSPro to both pancreatic tumor and spleen tissue slices, profiling ten distinct cell types in situ. By integrating laser microdissection with PSPro, they enabled direct comparison of spatially distinct cell subpopulations within the same tissue section, revealing spatial proteome heterogeneity with unprecedented granularity.

Protocol Parameters

• Antibody Selection: Use highly specific primary antibodies validated for fixed tissue labeling to ensure cell-type selectivity.
• Labeling Reagent Concentration: Employ optimized biotin-phenol and HRP concentrations to maximize labeling efficiency without compromising specificity (as detailed in the study).
• Incubation Time: Fine-tune enzymatic labeling duration (typically minutes) to prevent excessive diffusion and maintain spatial fidelity.
• Affinity Purification: Use streptavidin-based pulldown to enrich labeled proteins prior to proteomic analysis.
• Integration with LMD: If analyzing subregions, perform laser microdissection after antibody labeling but before affinity purification to retain spatial information.
• Controls: Include isotype and no-antibody controls to assess background labeling and non-specific binding.

Core Findings and Why They Matter

Applying PSPro to both tumor and spleen tissue slices, the authors successfully enriched and identified thousands of proteins from ten distinct cell types in a single experiment. This approach unveiled the spatial heterogeneity of cancer and immune cell subpopulations within pancreatic tumor slices, an insight critical for understanding tissue microenvironments and disease progression. Notably, benchmarking against flow cytometry- and LMD-based workflows confirmed PSPro’s robust selectivity, high proteome coverage, and compatibility with spatially complex samples (Mao et al., 2025).

The shift from the conventional “antibody-epitope” paradigm to an “antibody-cell-type proteome” model marks a significant advance, providing a scalable, user-friendly solution for spatial biology researchers. The ability to resolve spatial proteome landscapes at sub-micrometer resolution—and to do so with high throughput—empowers new avenues for dissecting cell-cell interactions, biomarker discovery, and tissue pathophysiology.

Comparison with Existing Internal Articles

Recent internal articles, such as Enhancing Detection: Real-World Scenarios with Cy3 TSA Fluorescence System Kit, emphasize the challenge of detecting low-abundance biomolecules in cell-based assays. These resources highlight the practical role of tyramide signal amplification for boosting fluorescence microscopy detection sensitivity, particularly in immunohistochemistry (IHC) and immunocytochemistry (ICC). Similarly, Cy3 TSA Fluorescence System Kit: Signal Amplification for Challenging Targets demonstrates how TSA-based approaches can reliably reveal proteins and nucleic acids at previously undetectable levels. While these articles focus on enhancing detection at the imaging level, the PSPro method from Mao et al. extends these principles to the proteomics domain, using proximity labeling to achieve comprehensive spatial profiling with cell-type resolution. Both strategies underscore the value of signal amplification—whether via TSA in microscopy or biotinylation in proteomics—for mapping complex tissue microenvironments, but PSPro uniquely enables simultaneous, multi-cell-type proteome capture and spatial heterogeneity analysis within a single workflow.

Limitations and Transferability

Despite its strengths, PSPro is not without limitations. Antibody specificity and tissue permeability can influence labeling precision, and incomplete coverage of the proteome is possible if marker antibodies are unavailable for certain cell types. The method’s reliance on high-quality antibodies and optimized labeling chemistry also introduces variables that may impact reproducibility across tissue types or experimental settings. Transferability to non-fixed or highly autofluorescent tissues may require further protocol adaptation. Nevertheless, the approach is broadly applicable to diverse research contexts, provided that antibody reagents and labeling conditions are carefully validated.

Research Support Resources

Researchers seeking to implement similar spatial proteome profiling or to enhance signal amplification in immunohistochemistry, immunocytochemistry, or in situ hybridization can benefit from commercially available tools. The Cy3 TSA Fluorescence System Kit (SKU K1051) from APExBIO utilizes tyramide signal amplification to boost detection sensitivity, facilitating robust fluorescence microscopy detection of low-abundance targets in fixed cells and tissues. This system employs HRP-linked secondary antibodies to generate dense, covalently localized Cy3 fluorescence (excitation 550 nm, emission 570 nm), supporting workflows analogous to the signal amplification principles underpinning PSPro. For practical protocol guidance and scenario-driven recommendations, researchers may reference resources such as Enhancing Detection: Real-World Scenarios and similar analyses, which offer workflow optimization tips for maximizing sensitivity and reproducibility in complex biological samples.